Arteris, Inc. (NASDAQ:AIP) CEO Sells $601,329.96 in Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 58,212 shares of the business’s stock in a transaction that occurred on Monday, December 30th. The stock was sold at an average price of $10.33, for a total transaction of $601,329.96. Following the sale, the chief executive officer now owns 10,020,588 shares of the company’s stock, valued at $103,512,674.04. This represents a 0.58 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

K Charles Janac also recently made the following trade(s):

• On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The stock was sold at an average price of $10.42, for a total transaction of $631,285.28.
• On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The shares were sold at an average price of $10.01, for a total transaction of $141,941.80.
• On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total value of $180,702.72.
• On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total value of $10,656.36.

Arteris Stock Performance

Shares of NASDAQ:AIP traded up $1.70 on Thursday, reaching $11.89. The company’s stock had a trading volume of 1,350,670 shares, compared to its average volume of 169,888. Arteris, Inc. has a 52-week low of $4.83 and a 52-week high of $11.90. The stock has a market capitalization of $477.70 million, a P/E ratio of -12.39 and a beta of 1.25. The stock’s 50-day moving average is $8.69 and its two-hundred day moving average is $8.00. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16.

Hedge Funds Weigh In On Arteris

Several institutional investors have recently added to or reduced their stakes in the stock. US Bancorp DE acquired a new position in shares of Arteris during the third quarter worth about $34,000. The Manufacturers Life Insurance Company acquired a new position in Arteris during the 2nd quarter worth approximately $86,000. Algert Global LLC purchased a new position in shares of Arteris during the 2nd quarter worth approximately $115,000. MetLife Investment Management LLC lifted its holdings in shares of Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after buying an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Arteris in the third quarter valued at approximately $226,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

Analyst Ratings Changes

Separately, Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 price objective on shares of Arteris in a research note on Wednesday, November 6th.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.